Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Hematologic Neoplasms 1 Coronavirus Infections 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 COVID-19 1

Interventions

Fluorouracil 87 Leucovorin 78 Oxaliplatin 77 Irinotecan 76 Bevacizumab 50 Cetuximab 42 Capecitabine 42 Panitumumab 17 Folfox protocol 16 Floxuridine 11 Chemotherapy, Adjuvant 11 regorafenib 10 IFL protocol 10 Nivolumab 9 Drug Therapy 9 trifluridine tipiracil drug combination 8 Surgical Procedures, Operative 8 Neoadjuvant Therapy 8 sargramostim 7 pembrolizumab 7 XELOX 7 Specimen Handling 7 Biopsy 7 Trastuzumab 6 Radiotherapy 6 Magnetic Resonance Spectroscopy 6 HMPL-013 6 tislelizumab 5 encorafenib 5 Trifluridine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colonic Neoplasms × HuMax-IL8 × Clear all

NCT03026140 2026-03-05

NICHE

The Netherlands Cancer Institute

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡